1 Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis" 95 : 622-626, 2010
2 Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation" 100 : 2367-2373, 2002
3 Fischer A, "Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation" 76 : 263-268, 1985
4 Stéphan JL, "Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A" 82 : 2319-2323, 1993
5 Lilleyman JS, "The treatment of familial erythrophagocytic lymphohistiocytosis" 46 : 468-470, 1980
6 Ambruso DR, "Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213" 45 : 2516-2520, 1980
7 Henter JI, "Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis" 2 : 1402-, 1986
8 Stinchcombe JC, "Secretory mechanisms in cell-mediated cytotoxicity" 23 : 495-517, 2007
9 Marsh RA, "Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab" 60 : 101-109, 2013
10 Schechter T, "Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens" 10 : 1101-1106, 2014
1 Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis" 95 : 622-626, 2010
2 Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation" 100 : 2367-2373, 2002
3 Fischer A, "Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation" 76 : 263-268, 1985
4 Stéphan JL, "Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A" 82 : 2319-2323, 1993
5 Lilleyman JS, "The treatment of familial erythrophagocytic lymphohistiocytosis" 46 : 468-470, 1980
6 Ambruso DR, "Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213" 45 : 2516-2520, 1980
7 Henter JI, "Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis" 2 : 1402-, 1986
8 Stinchcombe JC, "Secretory mechanisms in cell-mediated cytotoxicity" 23 : 495-517, 2007
9 Marsh RA, "Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab" 60 : 101-109, 2013
10 Schechter T, "Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens" 10 : 1101-1106, 2014
11 Marsh RA, "Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation" 116 : 5824-5831, 2010
12 O'Brien MM, "Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis" 50 : 381-383, 2008
13 Allen CE, "Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis" 2015 : 177-182, 2015
14 Feldmann J, "Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)" 115 : 461-473, 2003
15 Lehmberg K, "Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents" 170 : 539-549, 2015
16 Ravelli A, "Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis:diagnosis, genetics, pathophysiology and treatment" 13 : 289-298, 2012
17 Ohadi M, "Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping" 64 : 165-171, 1999
18 Henter JI, "Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis" 80 : 428-435, 1991
19 Meeths M, "Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden" 62 : 346-352, 2015
20 Mahlaoui N, "Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients" 120 : e622-e628, 2007
21 Zhang K, "Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH" 118 : 5794-5798, 2011
22 Jordan MB, "How I treat hemophagocytic lymphohistiocytosis" 118 : 4041-4052, 2011
23 Scott RB, "Histiocytic medullary reticulosis" 234 : 194-198, 1939
24 Allen CE, "Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis" 50 : 1227-1235, 2008
25 Janka GE, "Hemophagocytic lymphohistiocytosis:pathogenesis and treatment" 2013 : 605-611, 2013
26 Chandrakasan S, "Hemophagocytic lymphohistiocytosis:advances in pathophysiology, diagnosis, and treatment" 163 : 1253-1259, 2013
27 Aricò M, "Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society" 10 : 197-203, 1996
28 서종진, "Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies" 대한혈액학회 50 (50): 131-139, 2015
29 Atteritano M, "Haemophagocytic syndrome in rheumatic patients. A systematic review" 16 : 1414-1424, 2012
30 Henter JI, "HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society" 28 : 342-347, 1997
31 Henter JI, "HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis" 48 : 124-131, 2007
32 Jessen B, "Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice" 4 : 448-, 2013
33 Horne A, "Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis" 140 : 327-335, 2008
34 Janka GE, "Familial hemophagocytic lymphohistiocytosis" 140 : 221-230, 1983
35 Farquhar JW, "Familial haemophagocytic reticulosis" 27 : 519-525, 1952
36 Gholam C, "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management" 163 : 271-283, 2011
37 Janka GE, "Familial and acquired hemophagocytic lymphohistiocytosis" 166 : 95-109, 2007
38 Koh KN, "Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party" 94 : 51-59, 2015
39 Ishii E, "Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group" 30 : 276-283, 1998
40 Trottestam H, "Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol" 118 : 4577-4584, 2011
41 Trottestam H, "Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol" 118 : 4577-4584, 2011
42 Henter JI, "Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis" 38 : 305-309, 2002
43 Jordan MB, "An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+T cells and interferon gamma are essential for the disorder" 104 : 735-743, 2004
44 Marsh RA, "Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes" 121 : 877-883, 2013
45 Fischer A, "Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis" 108 : 267-270, 1986
46 Ramos-Casals M, "Adult haemophagocytic syndrome" 383 : 1503-1516, 2014